Compounds for the treatment of hepatitis C

Details for Australian Patent Application No. 2010306803 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wang, Tao; Pendri, Annapurna; Zhang, Zhongxing; Zhai, Weixu; Li, Guo; Gerritz, Samuel; Scola, Paul Michael; Sun, Li-Qiang; Zhao, Qian; Mull, Eric

Agent A J Park

Pub. Number AU-A-2010306803

PCT Pub. Number WO2011/047119

Priority 61/251,466 14.10.09 US

Filing date 14 October 2010

Wipo publication date 21 April 2011

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/047119 Priority application(s): WO2011/047119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010306807-Anaerobically curable compositions

2010306801-Lithium-iron disulfide cell design